XBridge® and ACQUITY UPLC® Oligonucleotide C18 Columns by Waters
Manufacturer Waters
XBridge® and ACQUITY UPLC® Oligonucleotide C18 Columns for Synthetic Oligonucleotide Analysis and PurificationIon-pair, reversed-phase separation of detritylated oligonucleotides on sub-3 micron particles yields exceptional component resolution.UPLC ® technology increases sample throughput while maintaining necessary oligonucleotide component resolution.LC/UV and LC/MS methods for enhanced quantitative and qualitative oligonucleotides analyses.Various XBridge™ Oligonucleotide C 18 column dimens... Read more
XBridge® and ACQUITY UPLC® Oligonucleotide C18 Columns
Average Rating: 4.3
3 Scientists have reviewed this product
Status:
Reviewer
Member since: 2018
Organization: Aurobindo
-
- Ease of use
- After sales service
- Value for money
Nice column for basic compounds
Rating: 4.3
Application Area: Active pharmaceutical ingredient products
"It is more effective and simply using active pharmaceutical ingredient product and basic compounds are preferred for xbridge column and reputability and compare to other columns these are the rugged columns."
Review date: 05 Feb 2018 | XBridge® and ACQUITY UPLC® Oligonucleotide C18 Columns
Status:
Reviewer Member since: 2014
Organization: Aksaray University
-
- Ease of use
- After sales service
- Value for money
Rating: 4.3
Review date: 25 Mar 2014 | XBridge® and ACQUITY UPLC® Oligonucleotide C18 Columns
Application Area:Chromatography
"This column has good separation and high resolution at different conditions. The new stationary phase provide for various chromatographic application. My next research I will be use it. I recommend this product to all my colleague."
Review date: 25 Mar 2014 | XBridge® and ACQUITY UPLC® Oligonucleotide C18 Columns
Status:
Reviewer Member since: 2011
Organization: Janssen Pharmaceutica
-
- Ease of use
- After sales service
- Value for money
Rating: 4.3
Review date: 20 Sep 2011 | XBridge® and ACQUITY UPLC® Oligonucleotide C18 Columns
"Robust column, high pH range."
Review date: 20 Sep 2011 | XBridge® and ACQUITY UPLC® Oligonucleotide C18 Columns
XBridge® and ACQUITY UPLC® Oligonucleotide C18 Columns for Synthetic Oligonucleotide Analysis and Purification
Use of synthetic oligonucleotides for research, diagnostic, and therapeutic applications continues to increase. The availability of 2.5 μm HPLC or 1.7 μm UPLC ® technology particles in several column dimensions provides flexibility to meet various LC/UV or LC/MS application needs. Waters' stringent manufacturing and quality control procedures help ensure consistent batch-to-batch and column-to-column performance.
- Ion-pair, reversed-phase separation of detritylated oligonucleotides on sub-3 micron particles yields exceptional component resolution.
- UPLC ® technology increases sample throughput while maintaining necessary oligonucleotide component resolution.
- LC/UV and LC/MS methods for enhanced quantitative and qualitative oligonucleotides analyses.
- Various XBridge™ Oligonucleotide C 18 column dimensions address lab scale purification needs.
- 2nd generation hybrid-silica BEH Technology™ particles deliver exceptional column life.
Use of synthetic oligonucleotides for research, diagnostic, and therapeutic applications continues to increase. The availability of 2.5 μm HPLC or 1.7 μm UPLC ® technology particles in several column dimensions provides flexibility to meet various LC/UV or LC/MS application needs. Waters' stringent manufacturing and quality control procedures help ensure consistent batch-to-batch and column-to-column performance.
